Basic Science News at Duke School of Medicine

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

A team of Duke researchers describe a synthetic molecule that mimics the effects of compounds in the saliva of blood-sucking critters that can also be swiftly reversed, enabling clotting to resume when needed after treatment.

Discovery paves the way for more effective cancer treatments that benefit a larger group of patients.

Two School of Medicine faculty were among five Duke faculty members elected to the National Academy of Sciences (NAS) on April 30 in recognition of their distinguished and continuing achievements in original research.  New NAS members with appointments in the School of Medicine were:   David Beratan, PhD, R.J. Reynolds Professor of Chemistry, professor of biochemistry, and professor of physics. Beratan is developing theoretical approaches to understand the function of complex molecular and macromolecular systems. 

Experimental vaccine targets portions of the flu virus that don’t change

Cagla Eroglu, PhD, Chancellor’s Distinguished Professor of Cell Biology and Neurobiology in the School of Medicine, is one of two Duke University faculty elected to the American Academy of Arts & Sciences for 2024. 

Graduate students at Duke University School of Medicine have been honored by the National Science Foundation Graduate Research Fellowship Program (GRFP).    Alev M. Brigande and Daniel Quintero in the Duke Department of Neurobiology, along with Violet Beaty, Porter Krev Ellis, and Celeste Marin in the Duke Department of Biochemistry received fellowships, joining biochemistry student Dalal Azzam who earned the honor in 2022. 

Colin S. Duckett, PhD, and Chuan-Yuan Li, DSc, have been elected as 2023 fellows by the American Association for the Advancement of Science, one of the most distinguished lifetime honors in the scientific community.

Scientists at Duke University School of Medicine have long probed the mysteries of RNA, with an eye to harnessing its power for new and better therapies for cancer, diabetes, heart disease and more.

Dean’s Award for Research Excellence recognizes basic science achievements of PhD candidates and their impact beyond the lab.